Literature DB >> 17448844

Nitrous oxide does not aggravate postoperative emesis after orthognathic surgery in female and nonsmoking patients.

Tatsuya Ichinohe1, Yuzuru Kaneko.   

Abstract

PURPOSE: The purpose of this study was to evaluate the effect of supplemental nitrous oxide on postoperative nausea and vomiting (PONV) after propofol anesthesia for orthognathic surgery in female and nonsmoking patients. PATIENTS AND METHODS: We compared PONV in 28 ASA-I female nonsmoking patients undergoing orthognathic surgery. Anesthesia was induced with propofol combined with fentanyl, and tracheal intubation was facilitated with vecuronium. Anesthesia was maintained with propofol with or without nitrous oxide. No patient received neostigmine. PONV was assessed as score 0 (no PONV), score 1 (nausea), and score 2 (vomiting) during the 24-hour recovery period.
RESULTS: There were no differences in the patients' characteristics, operation, anesthesia and emergence time, fluid transfusion, blood loss, urine output, and total propofol and fentanyl doses between the 2 groups. There was also no difference in PONV score in 2 groups. Only 1 patient in each group vomited.
CONCLUSIONS: It is suggested that supplemental nitrous oxide does not aggravate PONV after propofol anesthesia for orthognathic surgery in female nonsmoking patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17448844     DOI: 10.1016/j.joms.2006.06.283

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  2 in total

1.  The effect of anesthetic technique on recovery after orthognathic surgery: a retrospective audit.

Authors:  Soudeh Chegini; Kevin D Johnston; Athanasios Kalantzis; Daljit K Dhariwal
Journal:  Anesth Prog       Date:  2012

2.  Multimodal protocol reduces postoperative nausea and vomiting in patients undergoing Le Fort I osteotomy.

Authors:  Carolyn Dicus Brookes; John Berry; Josiah Rich; Brent A Golden; Timothy A Turvey; George Blakey; Vincent Kopp; Ceib Phillips; Jay Anderson
Journal:  J Oral Maxillofac Surg       Date:  2014-08-11       Impact factor: 1.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.